HR:NYE-Healthcare Realty Trust Incorporated (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 16.45

Change

-0.25 (-1.50)%

Market Cap

N/A

Volume

2.82M

Analyst Target

USD 31.27
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.09 (+0.75%)

USD 94.56B
VTR Ventas Inc

-0.81 (-1.20%)

USD 29.08B
DOC Healthpeak Properties Inc

-0.35 (-1.69%)

USD 13.70B
CTRE CareTrust REIT Inc.

+0.26 (+1.01%)

USD 4.68B
AHR American Healthcare REIT, Inc.

+0.78 (+2.79%)

USD 4.18B
NHI National Health Investors Inc

-0.77 (-1.04%)

USD 3.08B
LTC LTC Properties Inc

-0.41 (-1.13%)

USD 1.64B
CHCT Community Healthcare Trust Inc

-0.20 (-1.08%)

USD 0.56B
UHT Universal Health Realty Income..

-0.28 (-0.67%)

USD 0.54B
GMRE-PA Global Medical REIT Inc

+0.03 (+0.10%)

USD 0.41B

ETFs Containing HR

IYR iShares U.S. Real Estate .. 0.00 % 0.42 %

-1.16 (0%)

N/A
XRE:CA iShares S&P/TSX Capped RE.. 0.00 % 0.61 %

+0.02 (+0%)

CAD 1.37B
SMDY 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.95% 27% F 39% F
Dividend Return 1.83% 71% C- 82% B
Total Return -1.12% 27% F 47% F
Trailing 12 Months  
Capital Gain 21.85% 60% D- 88% B+
Dividend Return 9.19% 86% B+ 93% A
Total Return 31.04% 67% D+ 91% A-
Trailing 5 Years  
Capital Gain -52.31% 23% F 7% C-
Dividend Return 38.30% 62% D 81% B-
Total Return -14.00% 31% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -11.70% 29% F 5% F
Dividend Return -2.79% 29% F 12% F
Total Return 8.91% 100% F 96% N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.61% 86% B+ 67% D+
Risk Adjusted Return -19.08% 29% F 11% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.